Brief: Processa Pharmaceuticals Announces Pricing Of $5 Mln Public Offering Priced At-The-Market Under Nasdaq Rules

Processa Pharmaceuticals

28/01/2025 01:31

Jan 27 (Reuters) - Processa Pharmaceuticals Inc
 PCSA.O :
    * PROCESSA PHARMACEUTICALS ANNOUNCES PRICING OF $5 MILLION
PUBLIC
OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES
    * PROCESSA PHARMACEUTICALS INC - PURCHASE PRICE PER SHARE
$0.615
FOR INSTITUTIONAL INVESTORS, $0.7975 FOR CEO AND BOARD

Source text:  ID:nGNX7qXyFC 
Further company coverage:  PCSA.O 

 ((Reuters.Briefs@thomsonreuters.com;))